Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Endocrine 1

Conditions

Prostatic Neoplasms 220Urinary Bladder Neoplasms 54Carcinoma, Renal Cell 53Neoplasms 27Non-Muscle Invasive Bladder Neoplasms 26Kidney Neoplasms 25Breast Neoplasms 17Carcinoma, Transitional Cell 15Adenocarcinoma 15Melanoma 11Disease 11Neoplasm Metastasis 10Colorectal Neoplasms 10Uterine Cervical Neoplasms 9Endometrial Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Stomach Neoplasms 7Ovarian Neoplasms 7Lung Neoplasms 7Clear-cell metastatic renal cell carcinoma 7Triple Negative Breast Neoplasms 6Testicular Neoplasms 6Recurrence 6Urologic Neoplasms 5Urinary Incontinence 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Pancreatic Neoplasms 5Head and Neck Neoplasms 5Carcinoma, Hepatocellular 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Neuroendocrine Prostate Cancer × Genitourinary × Clear all
NCT07024277 2025-06-17

Study of ZG006 in Participants With Neuroendocrine Prostate Cancer

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Phase 2 Not yet recruiting
60 enrolled
EndocrineGenitourinary

Neuroendocrine Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡